Blackstone, Bain in race for Mitsubishi pharma unit in up to $3.5b deal

Blackstone, Bain in race for Mitsubishi pharma unit in up to $3.5b deal

Source: Blackstone's social media

Global private equity firms Blackstone and Bain Capital are among final bidders for Mitsubishi Tanabe Pharma, a unit of Japan’s Mitsubishi Chemical Group, in a deal that could value it at between $3 billion and $3.5 billion, three sources said.